Exploring how coffee affects exercise performance and caffeine metabolism in athletes
The Effect of Coffee on People with High Intensity Exercise and the Characteristics of Caffeine Metabolism
This study tests how drinking coffee affects exercise performance and caffeine processing in healthy elite athletes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 24 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | All |
| Sponsor | Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences Academic / other |
| Locations | 1 site (Shenzhen, Guangdong) |
| Trial ID | NCT06712667 on ClinicalTrials.gov |
What this trial studies
This project investigates the relationship between coffee consumption and exercise performance, focusing on how caffeine metabolism affects athletic capabilities. Healthy elite athletes will participate in a series of controlled experiments where they will refrain from stimulant drinks for 24 hours prior. Each participant will undergo six exercise trials after consuming either decaffeinated coffee, regular coffee, or water, with measurements taken for exercise performance, heart rate, and caffeine levels in urine. The study aims to provide insights into the physiological effects of coffee on high-intensity exercise.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy adults aged 18-40 who are elite athletes.
Not a fit: Patients with conditions such as diabetes, hypertension, or other specified health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance athletic performance through optimized caffeine consumption strategies.
How similar studies have performed: Previous studies have shown varying effects of caffeine on exercise performance, but this specific approach focusing on elite athletes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Healthy adults 18-40 years old Exclusion Criteria: Diabetes Hypoglycemia Gout Osteoporosis Gastric ulcer Pancreatitis Intestinal obstruction Blood phobia Pathological hypo or hyper tension Impaired glucose tolerance Claustrophobia HIV,etc.
Where this trial is running
Shenzhen, Guangdong
- Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences — Shenzhen, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: John R Speakman, PhD
- Email: j.speakman@abdn.ac.uk
- Phone: 15810868669
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.